Prostate cancer risk for transgender women

Published On 2023-05-02 04:00 GMT | Update On 2024-05-13 11:30 GMT

Transgender women keep their prostates even after gender-affirming surgery, but the extent to which they remain at risk of prostate cancer has been unclear.

The study drew on 22 years of data from the Veterans Affairs Health System. Although the sample size was necessarily small, it is still the largest study of its kind. Transgender people often face discrimination and disparities, and there has been a growing acknowledgement of the complexities involved in their health care.

The study found 155 confirmed transgender women with prostate cancer and stratified them according to whether they had used estrogen: 116 had never used estrogen, 17 had once used estrogen but stopped before they were diagnosed with prostate cancer, and 22 were actively on estrogen.

The median age of diagnosis was 61 years, and 88 percent of the patients were white. Just 8 percent were Black, suggesting possible disparities affecting this group. Black cisgender men are at heightened risk of being diagnosed with and dying from prostate cancer.

The authors found that prostate cancer occurs in transgender women more frequently than published accounts might suggest, with about 14 prostate cancer cases per 10,000 transgender women.

Reference:

Farnoosh Nik-Ahd, et al,Journal of the American Medical Association,

Full View

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Isra Zaman

Isra Zaman is a Life Science graduate from Daulat Ram College, Delhi University, and a postgraduate in Biotechnology from Amity University. She has a flair for writing, and her roles at Medicaldialogues include that of a Sr. content writer and a medical correspondent. Her news pieces cover recent discoveries and updates from the health and medicine sector. She can be reached at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Prostate cancer risk for transgender women

Similar News

Urine Test Could Drastically Reduce Post-Surgery Scans for Kidney Cancer Patients: Study Finds

Waterjet Surgery for Enlarged Prostate: Study Finds It Effective Relief Without Impacting Sexual Well-Being

Semen Quality Could Be the Secret to a Longer Life, Study finds

Kidney Stones: Pushing Fragments Could Be Key to Reducing Recurrence Risk, Study Reveals

Combination Immunotherapy Shows Increased Survival and Antitumor Activity in Bladder Cancer Cases: Study

Danish Study Finds Air Pollution Impacts Male Fertility, and Traffic Noise with Female Infertility

European Commission approves Janssen-Cilag Balversa for adult patients with metastatic urothelial carcinoma

Study Explores Potential Impact of Microplastics Found in Penises on Fertility